• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

严重急性呼吸综合征：病死率和倍增时间的时间稳定性及地域差异

Severe acute respiratory syndrome: temporal stability and geographic variation in case-fatality rates and doubling times.

作者信息

Galvani Alison P, Lei Xiudong, Jewell Nicholas P

机构信息

University of California, Berkeley, California, USA.

出版信息

Emerg Infect Dis. 2003 Aug;9(8):991-4. doi: 10.3201/eid0908.030334.

DOI:10.3201/eid0908.030334
PMID:12967499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3020622/
Abstract

We analyzed temporal stability and geographic trends in cumulative case-fatality rates and average doubling times of severe acute respiratory syndrome (SARS). In part, we account for correlations between case-fatality rates and doubling times through differences in control measures. Factors that may alter future estimates of case-fatality rates, reasons for heterogeneity in doubling times among countries, and implications for the control of SARS are discussed.

摘要

我们分析了严重急性呼吸综合征（SARS）累积病死率和平均倍增时间的时间稳定性及地理趋势。部分原因在于，我们通过控制措施的差异来解释病死率与倍增时间之间的相关性。文中讨论了可能改变未来病死率估计的因素、各国倍增时间存在异质性的原因以及对SARS防控工作的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7e/3020622/e3bbef90e847/03-0334-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7e/3020622/5c385d680d3e/03-0334-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7e/3020622/fae4fa32a547/03-0334-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7e/3020622/7c06b6a1a409/03-0334-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7e/3020622/e3bbef90e847/03-0334-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7e/3020622/5c385d680d3e/03-0334-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7e/3020622/fae4fa32a547/03-0334-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7e/3020622/7c06b6a1a409/03-0334-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7e/3020622/e3bbef90e847/03-0334-F4.jpg

相似文献

1
Severe acute respiratory syndrome: temporal stability and geographic variation in case-fatality rates and doubling times.严重急性呼吸综合征：病死率和倍增时间的时间稳定性及地域差异
Emerg Infect Dis. 2003 Aug;9(8):991-4. doi: 10.3201/eid0908.030334.
2
[Relationship between the severity, course, fatality of severe acute respiratory syndrome patients and the timing of hospitalization].[严重急性呼吸综合征患者的病情严重程度、病程、病死率与住院时机的关系]
Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Apr;25(4):308-11.
3
[SARS--two months later. Development in China during the immediate future will probably determine the situation in the world].[非典——两个月后。中国近期的发展态势可能会决定全球的局势]
Lakartidningen. 2003 May 28;100(22):1970-3.
4
[Epidemiological features of severe acute respiratory syndrome in Beijing].[北京严重急性呼吸综合征的流行病学特征]
Zhonghua Liu Xing Bing Xue Za Zhi. 2003 Dec;24(12):1096-9.
5
[Severe acute respiratory syndrome: a global overview of the epidemic].[严重急性呼吸综合征：疫情的全球概述]
Salud Publica Mex. 2003 May-Jun;45(3):211-20.
6
[Relationship between epidemiological evidence and fatality rate in patients with severe acute respiratory syndrome].[严重急性呼吸综合征患者的流行病学证据与病死率之间的关系]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Jun;26(3):247-50.
7
Management and prevention of SARS in China.中国非典的管理与预防。
Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29;359(1447):1115-6. doi: 10.1098/rstb.2004.1491.
8
[Severe acute respiratory syndrome (SARS). Local infection--global panic].[严重急性呼吸综合征（SARS）。局部感染——全球恐慌]
Lakartidningen. 2003 Apr 17;100(16):1420-2, 1425.
9
[Severe acute respiratory syndrome in Guangdong Province of China: epidemiology and control measures].[中国广东省严重急性呼吸综合征：流行病学与防控措施]
Zhonghua Yu Fang Yi Xue Za Zhi. 2003 Jul;37(4):227-32.
10
Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS.中医药治疗非典有效性的统计证据。
Phytother Res. 2004 Jul;18(7):592-4. doi: 10.1002/ptr.1485.

引用本文的文献

1
Theoretical Epidemiology Needs Urgent Attention in China.理论流行病学在中国亟需关注。
China CDC Wkly. 2024 May 24;6(21):499-502. doi: 10.46234/ccdcw2024.096.
2
Assessing Early Heterogeneity in Doubling Times of the COVID-19 Epidemic across Prefectures in Mainland China, January-February, 2020.评估2020年1月至2月中国内地各省份新冠疫情倍增时间的早期异质性
Epidemiologia (Basel). 2021 Mar 11;2(1):95-113. doi: 10.3390/epidemiologia2010009.
3
Doubling time of infectious diseases.传染病倍增时间。

本文引用的文献

1
Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong.香港严重急性呼吸系统综合症病原体传播的流行病学决定因素。
Lancet. 2003 May 24;361(9371):1761-6. doi: 10.1016/S0140-6736(03)13410-1.
2
Identification of a novel coronavirus in patients with severe acute respiratory syndrome.在严重急性呼吸综合征患者中鉴定出一种新型冠状病毒。
N Engl J Med. 2003 May 15;348(20):1967-76. doi: 10.1056/NEJMoa030747. Epub 2003 Apr 10.
3
A cluster of cases of severe acute respiratory syndrome in Hong Kong.
J Theor Biol. 2022 Dec 7;554:111278. doi: 10.1016/j.jtbi.2022.111278. Epub 2022 Sep 13.
4
Identifying spatiotemporal patterns of COVID-19 transmissions and the drivers of the patterns in Toronto: a Bayesian hierarchical spatiotemporal modelling.识别 COVID-19 在多伦多的时空传播模式及其驱动因素：贝叶斯分层时空建模。
Sci Rep. 2022 Jun 7;12(1):9369. doi: 10.1038/s41598-022-13403-x.
5
Lockdowns, Community Mobility Patterns, and COVID-19: A Retrospective Analysis of Data from 16 Countries.封锁、社区流动模式与 COVID-19：对 16 个国家数据的回顾性分析
Healthc Inform Res. 2022 Apr;28(2):160-169. doi: 10.4258/hir.2022.28.2.160. Epub 2022 Apr 30.
6
The determinants of the changing speed of spread of COVID-19 across Italy.新冠病毒在意大利传播速度变化的决定因素。
Epidemiol Infect. 2022 May 6;150:1-26. doi: 10.1017/S095026882200084X.
7
Population Mobility, Lockdowns, and COVID-19 Control: An Analysis Based on Google Location Data and Doubling Time from India.人口流动、封锁与新冠疫情防控：基于谷歌位置数据和印度倍增时间的分析
Healthc Inform Res. 2021 Oct;27(4):325-334. doi: 10.4258/hir.2021.27.4.325. Epub 2021 Oct 31.
8
Early Spatiotemporal Patterns and Population Characteristics of the COVID-19 Pandemic in Southeast Asia.东南亚新冠疫情的早期时空模式及人口特征
Healthcare (Basel). 2021 Sep 16;9(9):1220. doi: 10.3390/healthcare9091220.
9
Precision therapeutic targets for COVID-19.针对 COVID-19 的精准治疗靶点。
Virol J. 2021 Mar 29;18(1):66. doi: 10.1186/s12985-021-01526-y.
10
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.2020 年 8 月至 9 月印度 SARS-CoV-2 抗体血清阳性率：第二次全国家庭血清学调查结果。
Lancet Glob Health. 2021 Mar;9(3):e257-e266. doi: 10.1016/S2214-109X(20)30544-1. Epub 2021 Jan 27.
香港出现的严重急性呼吸系统综合症病例群。
N Engl J Med. 2003 May 15;348(20):1977-85. doi: 10.1056/NEJMoa030666. Epub 2003 Mar 31.
4
Identification of severe acute respiratory syndrome in Canada.加拿大严重急性呼吸综合征的识别。
N Engl J Med. 2003 May 15;348(20):1995-2005. doi: 10.1056/NEJMoa030634. Epub 2003 Mar 31.
5
Ecological and immunological determinants of influenza evolution.流感病毒进化的生态与免疫决定因素
Nature. 2003 Mar 27;422(6930):428-33. doi: 10.1038/nature01509.
6
Seroprevalence of IgG antibodies against Chlamydia pneumoniae in Chinese, Malays and Asian Indians in Singapore.新加坡华人、马来人和印度裔亚洲人中抗肺炎衣原体IgG抗体的血清流行率。
Int J Epidemiol. 2002 Oct;31(5):1001-7. doi: 10.1093/ije/31.5.1001.